Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEFORM
NCT05606718Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
dapagliflozin
Beyond the preview
Go deeper on NCT05606718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05606718.